Showing results (21-30 of 173) with videos related to
Sort By:
Pageof 18
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Patterns of molecular response to and relapse after combination of sorafenib, idarubicin, and cytarabine in patients with FLT3 mutant acute myeloid leukemiaAref Al-Kali, Jorge Cortes, Stefan Faderl, et al.Transfusion|October 9, 2015
ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioningMehrdad Hefazi, Mark Litzow, William Hogan, et al.Cell Research|October 10, 2018
A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitorsFei Yan, Aref Al-Kali, Zijie Zhang, et al.Systematic Reviews|September 20, 2018
A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndromeJehad Almasri, Hassan B Alkhateeb, Belal Firwana, et al.Developmental Dynamics : an Official Publication of the American Association of Anatomists|June 22, 2020
Understanding embryonic development for cell-based therapies of intervertebral disc degeneration: Toward an effort to treat disc degeneration subphenotypesSteven Tessier, Makarand V RisbudLeukemia Research|September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalitiesMehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.British Journal of Haematology|April 19, 2017
The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalitiesMark Gurney, Mrinal M Patnaik, Curtis A Hanson, et al.Cancer|September 17, 2010
Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemiaAref Al-Kali, Hagop Kantarjian, Jianqin Shan, et al.Respirology Case Reports|February 15, 2023
Selective IgG2-deficiency in yellow nail syndromeSteven Tessier, Santo Longo, Firas IdoLeukemia Research|October 11, 2016
Deletion 5q is frequent in myelodysplastic syndrome (MDS) patients diagnosed with interstitial lung diseases (ILD): Mayo Clinic experienceRama Nanah, Darci Zblewski, Mrinal S Patnaik, et al.Pageof 18